European Heart Journal Advance Access originally published online on February 15, 2005
European Heart Journal 2005 26(6):623-624; doi:10.1093/eurheartj/ehi134
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
Oral glucose tolerance test or metabolic syndrome criteria to predict risk in patients with coronary heart disease?: reply
Department of Cardiology
Karolinska University Hospital Solne
17176 Stockholm, Sweden
Tel: +46 8 517 70461
Fax: +46 8 31 10 44
E-mail address: malgorzata.bartnik@medks.ki.se
E-mail address: lars.ryden@medks.ki.se
| The first 10% of the full text of this article appears below. |
We are grateful for your interest in our article and your comments are indeed valid and important. Abnormal glucose metabolism is part of the metabolic syndrome as an optional or necessary component depending on the definition by the US National Cholesterol Education Program (NCEP) Adult Treatment Panel III or